Home/Companies/Abridge vs HeartFlow

Company pair · Health

Abridge vs HeartFlow

Health Abridge private HeartFlow public US-headquartered No Canborsa market

Abridge and HeartFlow are often weighed against each other in health.

On this pageSide by side Valuation marks What each discloses Verdict FAQ

AbridgePRIVATE · US

HeartFlowPUBLIC · US

Last valuation$5.3B$1.57B

Basis Post-money Basis undisclosed

As ofApr 2026Aug 2025

Founded20182007

Employees≈200≈860

On CanborsaNo marketNo market

At a glance

$5.3B

AbridgePost-money, Series E extension · Apr 2026

$1.57B

HeartFlowIPO · Aug 2025

A dated print and a public quote stay on separate scales

Gap

0 of 2

On CanborsaNeither company has a market

Head-to-head · field by field

Abridge vs HeartFlow — side by side

Field

AbridgePRIVATE · FOUNDED 2018

HeartFlowPUBLIC · FOUNDED 2007

Last valuation

$5.3B Post-money

$1.57B Basis undisclosed

Valuation date

1 Apr 2026

7 Aug 2025

Latest round

Series E extension

IPO

Round size

$316M

$316.67M

Named investors

Andreessen Horowitz IVP Elad Gil Lightspeed Venture Partners

Bain Capital Life Sciences Baillie Gifford Capricorn Investment Group Hayfin Capital Management

Founded

2018

2007

Employees (est.)

≈200

≈860

Sector & HQ

Healthcare technology and AI (AI-powered clinical documentation) · 🇺🇸 US

Medical AI / cardiac diagnostics · 🇺🇸 US

Status & market

Private — no Canborsa market

Public — no Canborsa market

Valuation · both companies on one scale

Valuation marks

Each bar is the last disclosed mark — $5.3B for Abridge (post-money, Apr 2026) and $1.57B for HeartFlow (basis undisclosed, Aug 2025).

Abridge

$5.3BPost-money · Apr 2026

HeartFlow

$1.57Bbasis undisclosed · Aug 2025

ABRIDGE · $5.3B · APR 2026HEARTFLOW · $1.57B · AUG 2025

Abridge vs HeartFlow · what each company discloses

What each company discloses, and what it leaves out

AbridgePRIVATEHealth · US · 2018

+Last disclosed mark $5.3B — post-money, Apr 2026.

+Founded 2018 .

+≈200 employees.

+Latest round: Series E extension, $316M raised, led by Andreessen Horowitz.

HeartFlowPUBLICHealth · US · 2007

+Last disclosed mark $1.57B — basis undisclosed, Aug 2025.

+Founded 2007 .

+≈860 employees.

+Latest round: IPO, $316.67M raised.

Verdict

Verdict

The $5.3B tells you…

What an investor paid for newly issued shares — a primary round, priced post-money.

How much capital arrived with it:$316M, led by Andreessen Horowitz in Apr 2026.

A dated print: it moves only when a newer round is announced.

The $1.57B tells you…

At least one valuation basis is undisclosed, so the two numbers stay side by side, each with its own chip, and no ratio is scored. HeartFlow is public, and there is no Canborsa market on either name — the dated prints above stay separate from any live quote.